Montibus Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Montibus Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$5.66M	Buy	+570,491	New	+$5.6M	0.61%	74

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Montibus Capital Management's IRWD Position: Q3 2013 in Review

Montibus Capital Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2013: 570,491 shares worth $5.66M. The stake represents 0.61% of the portfolio and ranks #74 among its holdings.

124 funds tracked by Wall St. Rank hold IRWD as of Q3 2013.

Montibus Capital Management held 570,491 shares of Ironwood Pharmaceuticals worth $5.66M as of Q3 2013.
Ironwood Pharmaceuticals was a new Montibus Capital Management position in Q3 2013.
Ironwood Pharmaceuticals made up 0.61% of Montibus Capital Management's portfolio in Q3 2013, its #74 holding.
124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2013.

Based on Montibus Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.